Peripheral Vascular Devices | Canada | 2017 | Market Insights
The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure volume expansion. However, cost constraints in the publicly funded health care system continue to hinder penetration of endovascular treatment; as a result, the Canadian PV device market will grow modestly through 2025, despite rising PVD diagnosis rates.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Canada across a 10-year period.